Prognosis of patients with advanced melanoma.
Eberlein
T J
TJ
D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016207:Cytokines / Q000627:therapeutic use; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D016233:Immunotherapy, Active; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D009367:Neoplasm Staging; D011379:Prognosis; D012074:Remission Induction; D012878:Skin Neoplasms / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate
D016207:Cytokines